The guidance encourages the use of Bayesian statistics in drug trials. Instead of starting from scratch and only adding new ...
Disclaimer: This Working Paper should not be reported as representing the views of the IMF.The views expressed in this Working Paper are those of the author(s) and do not necessarily represent those ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results